JAK2 V617F(QUALITATIVE) MUTATION

A molecular test to detect the JAK2 V617F mutation in blood or bone marrow. A key diagnostic marker for myeloproliferative neoplasms (MPNs) like polycythemia vera.

Typically prescribed for: Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis etc.

Report After: 5 Days